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Background: Signal peptide peptidase (SPP) is a multi-transmembrane aspartic protease involved in
intramembrane-regulated proteolysis (RIP). RIP proteases mediate various key life events by releasing bioactive
peptides from the plane of the membrane region. We have previously isolated Arabidopsis SPP (AtSPP) and found
that this protein is expressed in the ER. An AtSPP-knockout plant was found to be lethal because of abnormal
pollen formation; however, there is negligible information describing the physiological function of AtSPP. In this
study, we have investigated the proteolytic activity of AtSPP to define the function of SPPs in plants.
Results: We found that an n-dodecyl-ß-maltoside (DDM)-solubilized membrane fraction from Arabidopsis cells
digested the myc-Prolactin-PP-Flag peptide, a human SPP substrate, and this activity was inhibited by (Z-LL)2-
ketone, an SPP-specific inhibitor. The proteolytic activities from the membrane fractions solubilized by other
detergents were not inhibited by (Z-LL)2-ketone. To confirm the proteolytic activity of AtSPP, the protein was
expressed as either a GFP fusion protein or solely AtSPP in yeast. SDS-PAGE analysis showed that migration of the
fragments that were cleaved by AtSPP were identical in size to the fragments produced by human SPP using the
same substrate. These membrane-expressed proteins digested the substrate in a manner similar to that in
Arabidopsis cells.
Conclusions: The data from the in vitro cell-free assay indicated that the membrane fraction of both Arabidopsis
cells and AtSPP recombinantly expressed in yeast actually possessed proteolytic activity for a human SPP substrate.
We concluded that plant SPP possesses proteolytic activity and may be involved in RIP.
Keywords: Signal peptide peptidase (SPP), Endoplasmic reticulum (ER), Aspartic protease, Regulated intramembrane
proteolysis (RIP), Arabidopsis thalianaBackground
Signal peptide peptidase (SPP) is a multi-transmembrane
aspartic protease that contains two catalytic aspartates; the
conserved YD and GXGD motifs in the sixth and seventh
transmembrane domains, respectively [1]. SPP is located in
the endoplasmic reticulum (ER) and the substrates of SPP
are Type II membrane proteins, in which the locations of
the N- and C-termini of these substrate proteins are in the
cytosol and lumen, respectively. SPPs have been identified in
human [1], mouse [2], zebrafish [3], fruit fly [4],
Caenorhabditis elegans [5], Arabidopsis thaliana [6] and* Correspondence: asakura@mail.ecc.u-tokyo.ac.jp
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reproduction in any medium, provided the orOryza sativa [7]. Recessive lethal mutation studies of SPP in
Drosophila indicated that SPP is necessary for development
[4] and an SPP knockdown in zebrafish resulted in cell death
in the central nervous system [3]. Moreover, a SPP knock-
down in C. elegans led to embryonic death and an abnormal
molting phenotype [5]. These data indicate that the SPP
family is indispensable for survival. SPP appears to be
involved in regulated intramembrane proteolysis through
the cleavage of the substrate intramembrane region.
SPP promotes the intramembrane proteolysis of signal
peptides following the cleavage of newly synthesized
secretory or membrane proteins [8,9]. The resultant peptide
fragments act as bioactive peptides that are liberated from
the ER membrane. For example, the signal peptide frag-
ments of human leukocyte antigens (HLA)-A liberated bytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Substrate:myc-Prl-pp-Flag










Figure 1 Proteolytic activity of the membrane fraction of
“Deep” cell extracts. (A) Immunoblot analysis of the DDM
solubilized membrane fraction of “Deep” cells. The location of the
AtSPP protein is indicated by the white arrow. (B) Structure of the
substrate: the signal sequence of the bovine prolactin mutant (Prl-
pp) fused with a myc epitope tag at the N-terminus and a Flag tag
epitope at the C-terminus. (C) “Deep” cell membrane fractions
solubilized with 0.25% DDM were incubated for 3 h in the presence
of the inhibitor. Lane 1: control (without inhibitor); lane 2: 10 μM
(Z-LL)2-ketone; and lane 3: 20 μM L-685,458. The arrow indicates the
proteolytic products from the myc-Prl-PP-FLAG peptide detected
with an anti-myc antibody.
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presented to NK-cells for immune surveillance [10,11].
The secretory protein hormone preprolactin is also
processed by SPP and the resulting N-terminal frag-
ments are released into the cytosol [8]. Thereafter,
the fragments bind to calmodulin and enter into the
cellular signal transduction pathway [12]. In addition,
SPP participates in the maturation of the core protein
of the hepatitis C virus (HCV) [13]. SPP also pos-
sesses non-enzymatic functions, including molecular
chaperone activity. SPP interacts with the human
cytomegalovirus glycoprotein US2 and induces the
dislocation of MHC class I heavy chains to the prote-
asome system [14]. Moreover, based on the observa-
tion that SPP interacts with newly synthesized
membrane proteins in vitro, human SPP (HsSPP) in-
teracts with signal peptides and misfolded membrane
proteins that are removed during ER quality control.
However, SPP does not interact with all types of
membrane proteins [15]. Thus, the function of mam-
malian SPP has been examined, yet there are only a
few studies that have examined plant SPPs. We have
previously isolated AtSPP (At2g03120) in Arabidopsis
thaliana, and have shown that AtSPP is strongly
expressed in the shoot meristem of germination seeds
and in the inflorescence meristem during the repro-
ductive stage [6]. We have investigated a GFP-fused
AtSPP protein in cultured “Deep” cells and found that
this protein is localized in the ER. Moreover, subcel-
lular localization studies of endogenous AtSPP in
“Deep” cells by equilibrium sucrose density gradient
centrifugation also indicated that AtSPP is localized
in the ER [6]. The shoot meristem contains undiffer-
entiated cells that have the potential to differentiate
into all aerial parts of the plant [6]. Based on these
results, it is conceivable that AtSPP is involved in
regulating growth and differentiation in Arabidopsis.
This notion is supported by a knockout of the AtSPP
gene giving rise to a lethal phenotype [16]. However,
the target molecule of SPP in plants remains unre-
solved. Recently, it was reported that nodule-specific
cysteine rich polypeptides (NCR) mediate consecutive
differentiation events with symbiosomes in Medicago
truncatula [17]. NCR propeptides are likely to be
processed by the signal peptidase complex (SPC) and
converted to the active form. The highly correlated
expression of SPC with SPP suggests that NCR signal
peptides can be processed by SPP [18,19]. To reveal
the function of plant SPPs, it is important to examine
the proteolytic activity of SPPs.
Herein, we present evidence that the SPP of Arabidopsis
actually possesses proteolytic activity, suggesting that the
plant SPP cleaves the target proteins in the membrane
and releases bioactive peptides that function in signaltransduction pathways, similar to the phenomena observed
for other species.
Results
Preparation of the membrane fraction of “deep” cell
extracts and the proteolytic activity of this fraction
For the purposes of studying the proteolytic activity of
AtSPP, we have isolated the membrane fraction of
Arabidopsis root derived cultured “Deep” cells. The
AtSPP protein was detected by SDS-PAGE as a single
band in the membrane fraction of “Deep” cells
(Figure 1A). The deduced size of the protein estimated
from the primary sequence was 38 kDa. The band
representing AtSPP migrated further on the SDS-PAGE
than the estimated molecular weight. Nonetheless, such
anomalous electrophoretic migration has been shown
previously for ER fractions isolated from “Deep” cells [6].
Several detergents were tested for their suitability to
solubilize active AtSPP from the membranes. Digitonin,
CHAPS-, CHAPSO- and NP-40-solubilized membrane
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synthetic peptide myc-Prl-PP-Flag [20] (Figure 1B). Al-
though all of these membrane fractions showed proteo-
lytic activities, none were inhibited by the SPP-specific
inhibitor (Z-LL)2-ketone (data not shown). This indi-
cates that the proteolytic activity of the membrane frac-
tion was induced by proteases other than SPP. We then
tested whether an n-dodecyl-ß-maltoside (DDM)-solubi-
lized membrane fraction showed proteolytic activity, be-
cause human SPP has been shown to exhibit proteolytic
activity using this preparation [20]. As shown in





















Figure 2 Construction of GFP-fusion protein expression plasmid. (A) C
sequence of the primer. (B) SPP genes were amplified with primers describ
products were transformed into Saccharomyces cerevisiae by homologous rcleaved the myc-Prl-PP-Flag peptide and was inhibited
by (Z-LL)2-ketone, as well as L-685,458, an aspartic pro-
tease inhibitor that targets SPP or presenilin [21]. Based
on these results, we concluded that the DDM-
solubilized membrane fraction possesses SPP-like pro-
teolytic activity, and likely has activity from other
proteases.
AtSPP-GFP fusion protein expression in Saccharomyces
cerevisiae
To determine whether the proteolytic activity of the
DDM-solubilized “Deep” cell membrane fraction wasAmplify SPP gene
PCR fragment with vector  





















loning site of pRS426 GAL1-GFP and overlapping recombination
ed in the Materials and Methods. The SmaI digested vector and PCR
ecombination. yEGFP stands for enhanced green fluorescent protein.
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Figure 4 Expression of the SPP-GFP fusion protein in yeast.
(A) Soluble and membrane fractions were analyzed by 12% SDS-PAGE
using in-gel fluorescence. The protein concentrations loaded were as
follows: Soluble fractions in the left panel; lane 1, AtSPP-GFP, 117 μg; lane
2, AtSPP-GFP, 340 μg; lane 3, HsSPP-GFP, 56 μg; and lane 4, vector, 56 μg.
Membrane fractions in the right panel: lane 5, AtSPP-GFP, 306 μg; lane 6,
AtSPP-GFP, 1120 μg; lane 7, HsSPP-GFP, 158 μg; and lane 8, vector,
161 μg. Detection of GFP fluorescence in the gel was carried out by
exposure to blue light (EPI) at 460 nm with a cut-off filter. The arrows
indicate the location of the GFP fusion proteins. (B) Proteolytic activity of
the membrane fraction of GFP-fusion protein. Solubilized membrane
fractions of yeast cells overexpressing the vector control (183.1 μg)
HsSPP-GFP (197.5 μg) and AtSPP-GFP (55 μg) proteins were incubated
for 15 h in the presence or absence of the inhibitor. Lane 1: control
(without inhibitor); and lane 2: 50 μM (Z-LL)2-ketone. Arrows indicate the
proteolytic products from myc-Prl-PP-FLAG detected with the
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fusion protein (AtSPP-GFP) in yeast cells, as described
previously [22]. As shown in Figure 2, the linearized vec-
tor (pRS426- GAL1-GFP) and amplified PCR products
were transformed into S. cerevisiae BY2777. Figure 3
shows the confocal microscopy image of HsSPP-GFP
and AtSPP-GFP localization. Yeast cells transformed
with the vector alone did not exhibit any GFP fluores-
cence; however, fluorescence was detected in the HsSPP-
GFP- and AtSPP-GFP-transformed cells. These results
indicate that the AtSPP-GFP fusion protein was success-
fully expressed. We next confirmed the expression of
the fusion proteins by in-gel fluorescence. Yeast cells
were separated into soluble and membrane-bound frac-
tions after mechanical disruption. Fluorescent bands of
GFP-fusion proteins are shown in Figure 4A. No band
was detected in the soluble fraction. The 2% DDM-
solubilized membrane fraction band is indicated by the
white arrowheads. Moreover, the intensity of the AtSPP-
GFP band increased in a dose-dependent manner
(Figure 4A). These data suggest that AtSPP-GFP and
HsSPP-GFP are localized in the yeast membrane frac-
tion. Based on their primary sequences, the sizes of
AtSPP-GFP and HsSPP-GFP are estimated to be 65 and
72 kDa, respectively. AtSPP-GFP migrated at a size
smaller than 65 kDa, whereas HsSPP-GFP migrated at a
size more than 72 kDa. While the reasons underlying
this anomalous migration remain to be elucidated, previ-
ous Blue Native Polyacrylamide Gel Electrophoresis
(BN-PAGE) studies have shown that HsSPP forms a high
molecular mass complex under DDM-solubilized condi-
tions [23]. HsSPP and AtSPP may assemble into com-
plexes of different molecular masses.anti-myc antibody.In vitro cell-free assay using AtSPP overexpressed in yeast
Next, the membrane fractions containing GFP-fusion
proteins were examined for proteolytic activity using anVector HsSPP-GFP AtSPP-GFP
A B C
Figure 3 SPP-GFP fusion protein expression in yeast as
visualized by confocal microscopy. An aliquot of the yeast culture
cell suspension overexpressing the fusion protein was placed onto a
microscope slide to observe GFP fluorescence by microscopy. (A)
Fluorescence from the control cells harboring only the vector. GFP
fluorescence was not detected. (B) Transformation with HsSPP-GFP.
(C) Transformation with AtSPP-GFP.in vitro assay system. Both HsSPP-GFP and AtSPP-GFP
exhibited proteolytic activity in the in vitro assay. Faint
bands were detected in the lanes of the vector control.
However, this band was not inhibited by the (Z-LL)2-ke-
tone. This cleavage was due to an intrinsic proteinase
present in yeast. Though the rate of proteolytic activity
of AtSPP-GFP was weak, the activity was inhibited by
the (Z-LL)2-ketone, an SPP-specific inhibitor (Figure 4B).
Our results suggest that the AtSPP-GFP fusion protein
possesses proteolytic activity.
To confirm the proteolytic activity of AtSPP, we
expressed AtSPP without the GFP protein, thereby creat-
ing a protein construct that is closer to the native form.
DDM-solubilized yeast membrane fractions were ex-
tracted and AtSPP was detected by immunoblotting
using an anti-AtSPP antibody (Figure 5A). The arrow-
heads indicate the bands which specifically cross-reacted
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Figure 5 Identification of the proteolytic activity by
overexpressing AtSPP in yeast. (A) Immunoblot analysis of
DDM-solubilized membrane fraction overexpressing AtSPP in yeast
by using anti-AtSPP. Lane 1, vector control; lane 2, overexpression of
AtSPP in yeast; and lane 3, overexpression of HsSPP-GFP in yeast.
The filled-arrowhead indicates the monomer and the open-
arrowhead indicates the dimer. (B) Evaluation of the proteolytic
activity of AtSPP overexpressed in yeast. Proteolytic activity of the
membrane fraction of yeast cells overexpressing AtSPP with
inhibitor. Lane 1: control (without inhibitor); lane 2: 1 μM(Z-LL)2 small
capitor-ketone. The arrow indicates the proteolytic products from
myc small capitor-Prl-PP-FLAG peptide detected with the
anti-myc antibody.
Prl-23





Figure 6 Characterization of the cleavage site in the myc-Prl-
PP-FLAG peptide. Products of the myc-Prl-PP-FLAG peptide
proteolysis by various SPP proteins and standard peptides Prl-23
were separated by a Tris/Tricine urea gel and detected with an anti-
myc antibody. (A) Structure of the substrate Prl-23: Prl-23 is a N-
terminal fragment of myc-Prl-PP-FLAG peptide composed of 23
amino acid residues. (B) Lane 1, synthesized marker fragment of Prl-
23; lane 2, the membrane fraction of HEK293T cells; lane 3, HEK293T
cells with 10 μM (Z-LL)2-ketone inhibitor; lane 4, membrane fraction
of yeast cells overexpressing HsSPP-GFP; lane 5, membrane fraction
of “Deep” cell extracts; lane 6, the membrane fraction of yeast cells
overexpressing AtSPP. The black arrow indicates myc-Prl-PP-FLAG as
the original peptide and the white arrow indicates the position of
the proteolytic fragment.
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two bands. Electrophoretic migration of AtSPP in
“Deep” cells (Figure 1A) matched the lower band
detected in the yeast sample. Therefore, the lower mo-
lecular weight band may be a monomeric species and
the higher molecular weight band may represent a dimer
that is not affected by SDS treatment.
No bands were detected in the control vector (Figure 5A,
lane 1) and the HsSPP-GFP-transformed cell samples
(Figure 5A, lane 3). The proteolytic activity of AtSPP in the
presence of the (Z-LL)2-ketone is shown in Figure 5B. The
proteolytic activity toward myc-Prl-PP-FLAG is almost
completely inhibited by 1 μM (Z-LL)2-ketone. In summary,
our results confirm that AtSPP proteolytically cleaves the
myc-Prl-PP-FLAG substrate in vitro.
Comparison of the cleavage site of myc-Prl-PP-FLAG
using electrophoresis
Electrophoresis of the fragments from myc-Prl-PP-FLAG
was carried out and detected by an anti-myc antibody. AMALDI-TOF mass spectrometry study showed that human
SPP cleaved primarily at a single site between Leu-23 and
Leu-24 [17]. To compare the main cleavage sites, fragments
from myc-Prl-PP-FLAG cleaved by various SPPs were co-
electrophoresed with a synthesized marker fragment of
Prl-23 (Figure 6A) on a Tris/Tricine urea gel. Figure 6
shows that HEK293T cells expressing native human SPP
cleaved myc-Prl-PP-FLAG at the C-terminal of Leu-23 and
the SPP was inhibited by the (Z-LL)2-ketone. The fragment
arising from the digestion of the synthetic Prl-23 by the
overexpressed HsSPP-GFP fusion protein, membrane
fraction of “Deep” cells and recombinant AtSPP migrated
to the same location (Figure 6B). This result indicates that
AtSPP cleaved mainly myc-Prl-PP-FLAG at the same
sequence as the human SPP did.
Discussion
We have detected the AtSPP protein in a membrane
fraction of “Deep” cells (Figure 1A). The proteolytic
activity of the DDM-solubilized “Deep” cell membrane
fraction was blocked by the (Z-LL)2-ketone and L-
685,458 inhibitors (Figure 1C). These results confirm that
SPP exists in the membrane fraction of “Deep” cells;
however, the result also indicates that an aspartic protease
other than SPP exists in this fraction. Proteolytic activity
of SPP was detected in the DDM-solubilized membrane
fraction, but not in the other detergent-solubilized mem-
brane fractions prepared. Previous studies have shown
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thus, γ-secretase should not be active in the DDM solubi-
lized membrane fraction. Therefore, the difference in the
extent of inhibition brought about by (Z-LL)2-ketone and
L-685,458 may be due to the presence of an aspartic
protease other than γ-secretase. AtSPP and AtSPP-GFP
fusion proteins were successfully sorted toward the
membrane fraction and were expressed in S. cerevisiae.
Moreover, expressed AtSPP was observed to cleave the
substrate myc-Prl-PP-Flag.
We have observed proteolytic activity of endogenous SPP
in human HEK293T cells (Figure 6B). Similarly, the
proteolytic activity of the HsSPP-GFP fusion protein
overexpressed in yeast was found to efficiently process
preprolactin, because the preprolactin sequence is derived
from mammals. The signal sequences have some common
features, although there are no apparent common
sequences [25]. The signal sequence consists of a tripartite
structure: a central hydrophobic h-region, a positively
charged hydrophilic n-region and a C-terminal flanking
polar region. The h-region often contains helix-breaking
amino acids, such as glycine, proline, tyrosine and serine.
The central hydrophobic h-region of the preprolactin signal
sequence also has helix-destabilizing serine and asparagine
residues. Although the preprolactin sequence is not a native
substrate of the plant SPP, we have identified that AtSPP
can cleave at the typical position after the helix-breaking
amino acids in the central hydrophobic h-region, in a
similar manner to that in which human SPP cleaves
preprolactin.
Immunoblot analysis of the DDM-solubilized membrane
fraction from the AtSPP-overexpressing yeast cells using an
anti-AtSPP antibody detected two bands (Figure 5A). In
contrast, the DDM-solubilized “Deep” cell membrane frac-
tion extracted by the same method detected only one band
(Figure 1A). Recently, Miyashita et al. [23] suggested that
the proteolytic activity of Drosophila SPP requires its as-
sembly into high molecular weight complexes. HsSPP was
also reported to assemble into oligomeric complexes [26].
HsSPP can be isolated both as a monomer and as an SDS-
stable dimer. Under denaturing conditions, AtSPP was
isolated as a monomer in the “Deep” cell sample and as a
SDS-resistant dimer when overexpressed in yeast. Thus, it
is possible that AtSPP may assemble into both oligomeric
complexes and monomer under native conditions.
A previous paper showed that the sequence homology
around the active site motifs YD, GLGD and PAL is highly
conserved [1]. In contrast, the sequence of the N-terminus
of AtSPP and the transmembrane region 1 (TM1) differs
noticeably when compared with the sequences from other
species. Although the topological conformation to face the
membrane is reversed, the active site and PAL motif of
human SPP and presenilin are identical, suggesting a
common catalytic mechanism. The structural analysis ofthe initial substrate binding site by γ-secretase modulators
(GSMs) showed GSMs bind directly to the TM1 of PS and
affect the structure of the catalytic site [27]. Human SPP
was also affected by non-steroidal anti-inflammatory drugs
(NSAIDs ) that function as GSMs [20]. These data suggest
a crucial role of the TM1 in the intramembrane cleaving
mechanism. It is very interesting that AtSPP possessing a
different TM1 cleaved the same substrates as human SPP.
Hereafter, unraveling how the digestion occurs by modifica-
tion experiments in the TM1 region of AtSPP is required.
Currently, the native substrates targeted by SPP in plants
have not been identified. Further investigation of these
substrates is needed for understanding the function of SPPs
in plants. Research detailing the native substrates and the
role of SPPs in the plant life cycle is in progress.
Conclusion
“Deep” cells possess a signal peptide peptidase with pro-
teolytic activity.
AtSPP and AtSPP-GFP were expressed in the membrane
fraction of S. cerevisiae and shown to digest the HsSPP
substrate. The activities of AtSPP and AtSPP-GFP were
inhibited in the presence of an SPP-specific inhibitor. The
main cleavage site of AtSPP was identified as identical to
the site in human SPP. We conclude that plant SPPs
possess proteolytic activity, and that this activity is likely to
be involved in RIP.
Methods
Materials and cell culture
Myc-Prl-PP-Flag [28] was synthesized by BEX Co., LTD.
(Tokyo, Japan) with the sequence illustrated in Figure 1B.
Prl-23 was also synthesized by BEX Co., LTD. (Tokyo,
Japan) with the sequence illustrated in Figure 6A.
[(2R ,4R ,5S)-2-Benzyl-5-(t-butyloxycarbonylamino)-4-
hydroxy-6-phenylhexanoyl]-L-leucyl-L-phenylalanine amide
(L-685,458) [29] and 1,3-di-(N-carboxybenzoyl-L-leucyl-
L-leucyl) amino acetone ((Z-LL)2-ketone) [30] were
purchased from Calbiochem (San Diego, CA. USA) and
PEPTIDE INSTITUTE INC. (Osaka, Japan), respectively.
Arabidopsis root cells (“Deep” cells) were cultured at
22°C in Murashige and Skoog medium under dark
conditions. The rabbit polyclonal anti-AtSPP C terminus
antibody was obtained as described previously [6]. The
rabbit anti-c-myc polyclonal antibody was purchased
from Sigma-Aldrich (St. Louis, MO, USA).
Extraction of membrane fractions and immunoblotting
The extraction of membrane fractions was carried out as
described previously [20]. Briefly, a “Deep” cell suspen-
sion culture (100 ml) was centrifuged and the pellet was
collected. The cells were homogenized in (H) buffer
(50 mM HEPES, pH 7.0, 250 mM sucrose, 5 mM EDTA)
containing a complete protease inhibitor cocktail (Roche,
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French press at 1,000 psi and centrifuged at 3,000 × g for
10 min to remove cell debris and nuclei. The super-
natant was centrifuged again at 100,000 × g for 60 min
to isolate the microsomal fraction. Microsome pellets
were resuspended in 2% DDM-containing (H) buffer for
90 min on ice, and then centrifuged at 25,000 × g for
15 min. The solubilized membrane fraction was passed
through an Amicon Ultra-0.5 centrifugal filter device-10 K
(Millipore, Tokyo, Japan) and then diluted for the
assay. Yeasts were cultured at 30°C for 22 h after induc-
tion by galactose. The cells were collected and harvested
using a Multi-beads shocker (Yasui Kikai, Osaka, Japan).
Human embryonic kidney (HEK) 293 T cells were incu-
bated in Dulbecco’s modified Eagle’s medium (DMEM,
Sigma Aldrich, St. Louis, MO, USA) supplemented with
10% fetal bovine serum (Invitrogen, Carlsbad, CA, USA)
at 37°C under 5% CO2 and were collected and harvested
using a French press at 1,000 psi. The membrane frac-
tions of yeasts and HEK 293 T cells were obtained in a
similar manner to the process used for Arabidopsis cells
after harvesting. SDS-PAGE and immunoblotting were
performed as described previously [6].
Expression of GFP-fusion SPP in Saccharomyces cerevisiae
The GFP-fused protein-expression vector (pRS426
GAL1-GFP) [22] was kindly provided by Dr. Iwata (Im-
perial College, London). The S. cerevisiae BY2777
(MATa prb1-1122 prc1-407 pep4-3 ura3-52 leu2 trp1)
strain was provided by the National Bio-Resource Pro-
ject (NBRP), MEXT, Japan. This plasmid was composed
of a C-terminal yeast-enhanced green fluorescent protein
(yEGFP), which is lacking the N-terminal methionine,
fused with an octa-His tag, and harbors a GAL1 pro-
moter and URA selection marker (Figure 2). The SPP
protein sequence, lacking a stop codon, was inserted
into the reverse primer for GFP expression. DNA was
amplified with the following primer pair: HsSPP forward
primer (5′-accccggattctagaactagtggatcccccatggactcggcc
ctcagcgatc-3′) and reverse primer (5′-aaattgaccttgaaaata
taaattttcccctttctctttcttctccagccccttc-3′). AtSPP-GFP for-
ward primer (5′-accccggattctagaactagtggatcccccatgaag
aattgtgagagatttgc-3′) and reverse primer (5′-aaatt
gaccttgaaaatataaattttccccttcatcatgagctttattaacctc-3′). For
studying the expression of the protein without GFP, an-
other reverse primer was prepared, the AtSPP reverse
primer, (5′-aaattgaccttgaaaatataaattttcccctcattcatcatgagc
tttattaacc-3′) (Figure 2).
The expression plasmids were constructed as follows: the
expression vector (pRS426 GAL1-GFP) was linearized with
SmaI and the amplified fragment was inserted by homolo-
gous recombination using Frozen-EZ Yeast Transformation
II (Zymo Research, Irvine, CA, USA). The transformants
were selected by growing in the absence of the uracilmedium, as described previously [22]. The expression of
SPP-GFP was confirmed by confocal microscopy (FV10i-
LIV, Olympus Tokyo Japan). In-gel fluorescence was
performed using an Image Quant LAS-4000mini (GE
Healthcare, Amersham, Uppsala, Sweden).
In vitro cell-free assay
Membrane fractions solubilized by 0.25% DDM were in-
cubated at 37°C with 1 μM of the myc-Prl-PP-FLAG
peptide (BEX Co., Ltd., Tokyo, Japan) containing a pro-
tease inhibitor cocktail (Roche, Basel, Switzerland) for
the appropriate times. For the inhibitor assay, the reac-
tion mixtures were incubated in the presence or absence
of the (Z-LL)2-ketone), a SPP inhibitor, and L-685,458,
an aspartic protease inhibitor. Dimethyl sulfoxide was
used as a vehicle control. Products were separated on a
15% Tris/Tricine SDS gel containing 8 M urea, then
transferred to a 0.2-μm polyvinylidene difluoride mem-
brane (Whatman, Maidstone, UK), and detected with an
anti-c-myc antibody. Signal detection was performed
with the Image Quant LAS-4000mini (GE Healthcare)
using the ECL system (GE Healthcare).
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